866-997-4948(US-Canada Toll Free)

United States Recombinant Human Serum Albumin Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 103 Pages

In this report, the United States Recombinant Human Serum Albumin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Recombinant Human Serum Albumin in these regions, from 2012 to 2022 (forecast).

United States Recombinant Human Serum Albumin market competition by top manufacturers/players, with Recombinant Human Serum Albumin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Boehringer Ingelheim
Bristol-Myers Squibb
Celldex Therapeutics
Eli Liily
GlaxoSmithKline
Merck
Novartis
Regeneron Pharmaceuticals
Roche
Shire Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
OsrHSA
pHSA
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Recombinant Human Serum Albumin for each application, including
Medicine
Scientific Research
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Recombinant Human Serum Albumin Market Report 2017
1 Recombinant Human Serum Albumin Overview
1.1 Product Overview and Scope of Recombinant Human Serum Albumin
1.2 Classification of Recombinant Human Serum Albumin by Product Category
1.2.1 United States Recombinant Human Serum Albumin Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Recombinant Human Serum Albumin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 OsrHSA
1.2.4 pHSA
1.3 United States Recombinant Human Serum Albumin Market by Application/End Users
1.3.1 United States Recombinant Human Serum Albumin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Medicine
1.3.3 Scientific Research
1.3.4 Others
1.4 United States Recombinant Human Serum Albumin Market by Region
1.4.1 United States Recombinant Human Serum Albumin Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Recombinant Human Serum Albumin Status and Prospect (2012-2022)
1.4.3 Southwest Recombinant Human Serum Albumin Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Recombinant Human Serum Albumin Status and Prospect (2012-2022)
1.4.5 New England Recombinant Human Serum Albumin Status and Prospect (2012-2022)
1.4.6 The South Recombinant Human Serum Albumin Status and Prospect (2012-2022)
1.4.7 The Midwest Recombinant Human Serum Albumin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Recombinant Human Serum Albumin (2012-2022)
1.5.1 United States Recombinant Human Serum Albumin Sales and Growth Rate (2012-2022)
1.5.2 United States Recombinant Human Serum Albumin Revenue and Growth Rate (2012-2022)

2 United States Recombinant Human Serum Albumin Market Competition by Players/Suppliers
2.1 United States Recombinant Human Serum Albumin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Recombinant Human Serum Albumin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Recombinant Human Serum Albumin Average Price by Players/Suppliers (2012-2017)
2.4 United States Recombinant Human Serum Albumin Market Competitive Situation and Trends
2.4.1 United States Recombinant Human Serum Albumin Market Concentration Rate
2.4.2 United States Recombinant Human Serum Albumin Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Recombinant Human Serum Albumin Manufacturing Base Distribution, Sales Area, Product Type

3 United States Recombinant Human Serum Albumin Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Recombinant Human Serum Albumin Sales and Market Share by Region (2012-2017)
3.2 United States Recombinant Human Serum Albumin Revenue and Market Share by Region (2012-2017)
3.3 United States Recombinant Human Serum Albumin Price by Region (2012-2017)

4 United States Recombinant Human Serum Albumin Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Recombinant Human Serum Albumin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Recombinant Human Serum Albumin Revenue and Market Share by Type (2012-2017)
4.3 United States Recombinant Human Serum Albumin Price by Type (2012-2017)
4.4 United States Recombinant Human Serum Albumin Sales Growth Rate by Type (2012-2017)

5 United States Recombinant Human Serum Albumin Sales (Volume) by Application (2012-2017)
5.1 United States Recombinant Human Serum Albumin Sales and Market Share by Application (2012-2017)
5.2 United States Recombinant Human Serum Albumin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Recombinant Human Serum Albumin Players/Suppliers Profiles and Sales Data
6.1 Boehringer Ingelheim
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Recombinant Human Serum Albumin Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Boehringer Ingelheim Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb
6.2.2 Recombinant Human Serum Albumin Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bristol-Myers Squibb Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Celldex Therapeutics
6.3.2 Recombinant Human Serum Albumin Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Celldex Therapeutics Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Eli Liily
6.4.2 Recombinant Human Serum Albumin Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Eli Liily Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
6.5.2 Recombinant Human Serum Albumin Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 GlaxoSmithKline Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Merck
6.6.2 Recombinant Human Serum Albumin Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Merck Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novartis
6.7.2 Recombinant Human Serum Albumin Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Regeneron Pharmaceuticals
6.8.2 Recombinant Human Serum Albumin Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Regeneron Pharmaceuticals Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Roche
6.9.2 Recombinant Human Serum Albumin Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Roche Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Shire Pharmaceuticals
6.10.2 Recombinant Human Serum Albumin Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Shire Pharmaceuticals Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Recombinant Human Serum Albumin Manufacturing Cost Analysis
7.1 Recombinant Human Serum Albumin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Human Serum Albumin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Recombinant Human Serum Albumin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Human Serum Albumin Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Recombinant Human Serum Albumin Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Recombinant Human Serum Albumin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Recombinant Human Serum Albumin Sales Volume Forecast by Type (2017-2022)
11.3 United States Recombinant Human Serum Albumin Sales Volume Forecast by Application (2017-2022)
11.4 United States Recombinant Human Serum Albumin Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Recombinant Human Serum Albumin
Figure United States Recombinant Human Serum Albumin Market Size (K Pcs) by Type (2012-2022)
Figure United States Recombinant Human Serum Albumin Sales Volume Market Share by Type (Product Category) in 2016
Figure OsrHSA Product Picture
Figure pHSA Product Picture
Figure United States Recombinant Human Serum Albumin Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Recombinant Human Serum Albumin by Application in 2016
Figure Medicine Examples
Table Key Downstream Customer in Medicine
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Recombinant Human Serum Albumin Market Size (Million USD) by Region (2012-2022)
Figure The West Recombinant Human Serum Albumin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Recombinant Human Serum Albumin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Recombinant Human Serum Albumin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Recombinant Human Serum Albumin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Recombinant Human Serum Albumin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Recombinant Human Serum Albumin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Recombinant Human Serum Albumin Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Recombinant Human Serum Albumin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Recombinant Human Serum Albumin Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Recombinant Human Serum Albumin Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Recombinant Human Serum Albumin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Recombinant Human Serum Albumin Sales Share by Players/Suppliers
Figure 2017 United States Recombinant Human Serum Albumin Sales Share by Players/Suppliers
Figure United States Recombinant Human Serum Albumin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Recombinant Human Serum Albumin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Recombinant Human Serum Albumin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Recombinant Human Serum Albumin Revenue Share by Players/Suppliers
Figure 2017 United States Recombinant Human Serum Albumin Revenue Share by Players/Suppliers
Table United States Market Recombinant Human Serum Albumin Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Recombinant Human Serum Albumin Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Recombinant Human Serum Albumin Market Share of Top 3 Players/Suppliers
Figure United States Recombinant Human Serum Albumin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Recombinant Human Serum Albumin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Recombinant Human Serum Albumin Product Category
Table United States Recombinant Human Serum Albumin Sales (K Pcs) by Region (2012-2017)
Table United States Recombinant Human Serum Albumin Sales Share by Region (2012-2017)
Figure United States Recombinant Human Serum Albumin Sales Share by Region (2012-2017)
Figure United States Recombinant Human Serum Albumin Sales Market Share by Region in 2016
Table United States Recombinant Human Serum Albumin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Recombinant Human Serum Albumin Revenue Share by Region (2012-2017)
Figure United States Recombinant Human Serum Albumin Revenue Market Share by Region (2012-2017)
Figure United States Recombinant Human Serum Albumin Revenue Market Share by Region in 2016
Table United States Recombinant Human Serum Albumin Price (USD/Pcs) by Region (2012-2017)
Table United States Recombinant Human Serum Albumin Sales (K Pcs) by Type (2012-2017)
Table United States Recombinant Human Serum Albumin Sales Share by Type (2012-2017)
Figure United States Recombinant Human Serum Albumin Sales Share by Type (2012-2017)
Figure United States Recombinant Human Serum Albumin Sales Market Share by Type in 2016
Table United States Recombinant Human Serum Albumin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Recombinant Human Serum Albumin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Human Serum Albumin by Type (2012-2017)
Figure Revenue Market Share of Recombinant Human Serum Albumin by Type in 2016
Table United States Recombinant Human Serum Albumin Price (USD/Pcs) by Types (2012-2017)
Figure United States Recombinant Human Serum Albumin Sales Growth Rate by Type (2012-2017)
Table United States Recombinant Human Serum Albumin Sales (K Pcs) by Application (2012-2017)
Table United States Recombinant Human Serum Albumin Sales Market Share by Application (2012-2017)
Figure United States Recombinant Human Serum Albumin Sales Market Share by Application (2012-2017)
Figure United States Recombinant Human Serum Albumin Sales Market Share by Application in 2016
Table United States Recombinant Human Serum Albumin Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Human Serum Albumin Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Recombinant Human Serum Albumin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Recombinant Human Serum Albumin Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Recombinant Human Serum Albumin Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Recombinant Human Serum Albumin Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Recombinant Human Serum Albumin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Recombinant Human Serum Albumin Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Recombinant Human Serum Albumin Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Recombinant Human Serum Albumin Revenue Market Share in United States (2012-2017)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Recombinant Human Serum Albumin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celldex Therapeutics Recombinant Human Serum Albumin Sales Growth Rate (2012-2017)
Figure Celldex Therapeutics Recombinant Human Serum Albumin Sales Market Share in United States (2012-2017)
Figure Celldex Therapeutics Recombinant Human Serum Albumin Revenue Market Share in United States (2012-2017)
Table Eli Liily Basic Information List
Table Eli Liily Recombinant Human Serum Albumin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Liily Recombinant Human Serum Albumin Sales Growth Rate (2012-2017)
Figure Eli Liily Recombinant Human Serum Albumin Sales Market Share in United States (2012-2017)
Figure Eli Liily Recombinant Human Serum Albumin Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Recombinant Human Serum Albumin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Recombinant Human Serum Albumin Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Recombinant Human Serum Albumin Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Recombinant Human Serum Albumin Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Recombinant Human Serum Albumin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Recombinant Human Serum Albumin Sales Growth Rate (2012-2017)
Figure Merck Recombinant Human Serum Albumin Sales Market Share in United States (2012-2017)
Figure Merck Recombinant Human Serum Albumin Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Recombinant Human Serum Albumin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Recombinant Human Serum Albumin Sales Growth Rate (2012-2017)
Figure Novartis Recombinant Human Serum Albumin Sales Market Share in United States (2012-2017)
Figure Novartis Recombinant Human Serum Albumin Revenue Market Share in United States (2012-2017)
Table Regeneron Pharmaceuticals Basic Information List
Table Regeneron Pharmaceuticals Recombinant Human Serum Albumin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Regeneron Pharmaceuticals Recombinant Human Serum Albumin Sales Growth Rate (2012-2017)
Figure Regeneron Pharmaceuticals Recombinant Human Serum Albumin Sales Market Share in United States (2012-2017)
Figure Regeneron Pharmaceuticals Recombinant Human Serum Albumin Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Recombinant Human Serum Albumin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Recombinant Human Serum Albumin Sales Growth Rate (2012-2017)
Figure Roche Recombinant Human Serum Albumin Sales Market Share in United States (2012-2017)
Figure Roche Recombinant Human Serum Albumin Revenue Market Share in United States (2012-2017)
Table Shire Pharmaceuticals Basic Information List
Table Shire Pharmaceuticals Recombinant Human Serum Albumin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire Pharmaceuticals Recombinant Human Serum Albumin Sales Growth Rate (2012-2017)
Figure Shire Pharmaceuticals Recombinant Human Serum Albumin Sales Market Share in United States (2012-2017)
Figure Shire Pharmaceuticals Recombinant Human Serum Albumin Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Serum Albumin
Figure Manufacturing Process Analysis of Recombinant Human Serum Albumin
Figure Recombinant Human Serum Albumin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Serum Albumin Major Players/Suppliers in 2016
Table Major Buyers of Recombinant Human Serum Albumin
Table Distributors/Traders List
Figure United States Recombinant Human Serum Albumin Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Recombinant Human Serum Albumin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Recombinant Human Serum Albumin Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Recombinant Human Serum Albumin Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Recombinant Human Serum Albumin Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Recombinant Human Serum Albumin Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Recombinant Human Serum Albumin Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Recombinant Human Serum Albumin Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Recombinant Human Serum Albumin Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Recombinant Human Serum Albumin Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Recombinant Human Serum Albumin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Recombinant Human Serum Albumin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Recombinant Human Serum Albumin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *